The stock, which fell 5.8 percent on the day of the report, is currently down 4.2 percent since the report's release, while the large-cap OMXS30 index has risen by 3.1 percent.
Based on the estimates submitted after the interim report, Factset's consensus for this year's sales has been reduced by 2.7 percent, while consensus for next year has also been adjusted down by 2.7 percent.
Consensus for the adjusted EBITA result has been lowered by 3.5 percent for this year and cut by 3.5 percent for next year.
The average recommendation for the stock remains overweight.
The average target price has been decreased by 4.0 percent to 228.73 kronor, down from 238.33 kronor.
The proportion of positive recommendations now stands at 50 percent (previously 38), while the proportion of hold recommendations is 42 percent (54), and negative recommendations remain at 8 percent (8).
| Getinge | |||
| Share price development on report day | -5.8% | ||
| Date | 2026-02-09 | 2026-01-26 | Difference |
| Share price | 203.10 | 211.90 | -4.2% |
| Average target price | 228.73 | 238.33 | -4.0% |
| Difference target price vs current share price | 12.62% | 12.47% | |
| Consensus recommendation | Overweight | Overweight | |
| Proportion of positive recommendations | 50% | 38% | |
| Proportion of hold recommendations | 42% | 54% | |
| Proportion of negative recommendations | 8% | 8% | |
| Sales, current year | 34 866 | 35 824 | -2.7% |
| Sales, next year | 36 588 | 37 621 | -2.7% |
| Sales growth, next year | 4.9% | 5.0% | |
| Adjusted EBITA, current year | 4 973 | 5 152 | -3.5% |
| Adjusted EBITA, next year | 5 554 | 5 754 | -3.5% |
| Adjusted EBITA growth, next year | 11.7% | 11.7% | |
| Source: Factset |
